High Rate of Long-Term Survival for High-Risk Lymphoma Patients Treated With Hematopoietic Stem Cell Transplantation as Consolidation or Salvage Therapy

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 3104-3105

  Espigado, I ^a   Rios E ^a   Marin Niebla A ^a   Carmona, M ^a   Parody, R ^a   Perez Hurtado J M ^a   Marquez F J ^a   Urbano Ispizua, A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MORTALITY; PRIORITY JOURNAL; SALVAGE THERAPY; SCHOOL CHILD; SURVIVAL TIME; T CELL LYMPHOMA;

EID: 56049105687     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.092     Document Type: Article

References (6)

1. Van Besien K. The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma. Blood Rev 20 (2006) 235
2. Cashen A.F., and Bartlett N.L. Therapy of relapsed Hodgkin lymphoma. Blood Rev 21 (2007) 233
3. Villanueva M.L., and Vose J.M. The role of haematopoietic stem cell transplantation in non-Hodgkin lymphoma. Clin Adv Hematol Oncol 4 (2006) 521
4. Kim S.W., Tanimoto T.E., Hirabayashi N., et al. Myeloablative allogeneic haematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. Blood 108 (2006) 382
5. Kasamon Y.L. Blood or marrow transplantation for mantle cell lymphomas. Curr Opin Oncol 19 (2007) 128
6. Hahn T., Wolff S., Czuczman M., et al. The role of cytotoxic therapy with haematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review. Biol Blood Marrow Transplant 9 (2003) 667